Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ifrah

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|March 1, 1996
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapyN Ifrah, M Hunault, J P Jais, et al.
Bone Marrow Transplantation|January 1, 1991
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)D Blaise, D Guyotat, J Reiffers, et al.
Bone Marrow Transplantation|January 1, 1991
Intensive therapy for high grade multiple myeloma (MM)J L Harousseau, N Milpied, J P Jouet, et al.
Leukemia|June 1, 1995
Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (< 100 days). The SFGM (Société Française de Greffe de MoelleE Jourdan, D Maraninchi, J Reiffers, et al.
Bone Marrow Transplantation|July 9, 2009
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantationP Chevallier, T Prebet, P Turlure, et al.
Autoimmunity Reviews|April 2, 2013
Prognosis of vasculitis associated myelodysplasiaC Belizna, J F Subra, D Henrion, et al.
Leukemia & Lymphoma|January 1, 1993
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic resultsF Guilhot, J F Abgrall, J L Harousseau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's diseaseJ M Tourani, R Levy, P Colonna, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary resultsF Guilhot, J P Lamagnère, J L Harousseau, et al.
Leukemia|May 26, 2017
Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemiaM Tesio, A Trinquand, P Ballerini, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|March 1, 1996
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapyN Ifrah, M Hunault, J P Jais, et al.
Bone Marrow Transplantation|January 1, 1991
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)D Blaise, D Guyotat, J Reiffers, et al.
Bone Marrow Transplantation|January 1, 1991
Intensive therapy for high grade multiple myeloma (MM)J L Harousseau, N Milpied, J P Jouet, et al.
Leukemia|June 1, 1995
Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (< 100 days). The SFGM (Société Française de Greffe de MoelleE Jourdan, D Maraninchi, J Reiffers, et al.
Bone Marrow Transplantation|July 9, 2009
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantationP Chevallier, T Prebet, P Turlure, et al.
Autoimmunity Reviews|April 2, 2013
Prognosis of vasculitis associated myelodysplasiaC Belizna, J F Subra, D Henrion, et al.
Leukemia & Lymphoma|January 1, 1993
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic resultsF Guilhot, J F Abgrall, J L Harousseau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's diseaseJ M Tourani, R Levy, P Colonna, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary resultsF Guilhot, J P Lamagnère, J L Harousseau, et al.
Leukemia|May 26, 2017
Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemiaM Tesio, A Trinquand, P Ballerini, et al.
Pageof 13